Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (32), the stock would be worth ﷼311.48 (11% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 28.8 | ﷼280 |
0%
|
| 3-Year Average | 32 | ﷼311.48 |
+11%
|
| 5-Year Average | 29.7 | ﷼288.32 |
+3%
|
| Industry Average | 25.1 | ﷼243.94 |
-13%
|
| Country Average | 15 | ﷼145.82 |
-48%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 28.8 | 40.8 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
99.7B USD | 7.4 | 14.2 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.5B ZAR | 9.6 | 14 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.5B MYR | 13.9 | 36.9 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 3.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.8B BRL | 157.5 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.1B USD | 4.4 | 11.1 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
101.5B CNY | 17.3 | 30.1 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 32.2 | 61.9 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11B USD | 19.3 | 31.7 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11B USD | 5.5 | 6.9 |
Market Distribution
| Min | 1.5 |
| 30th Percentile | 10 |
| Median | 15 |
| 70th Percentile | 22.9 |
| Max | 894.4 |
Other Multiples
Dr Sulaiman Al-Habib Medical Services Group Co
Glance View
Dr. Sulaiman Al-Habib Medical Services Group Co., often recognized as a titan in the healthcare landscape of the Middle East, has woven a narrative marked by strategic expansion and unwavering commitment to quality patient care since its inception. Founded by the visionary Dr. Sulaiman Al-Habib, the company has grown to encapsulate a network of modern, state-of-the-art hospitals, medical centers, and pharmacies across Saudi Arabia, the United Arab Emirates, and Bahrain. This healthcare conglomerate is renowned for merging cutting-edge technology with experienced medical professionals to deliver comprehensive healthcare services, ranging from preventative care to complex surgical procedures. They have successfully carved a niche by emphasizing an integrated approach to treatment, thus creating a robust model that emphasizes patient safety and satisfaction as the core pillars of its operations. Revenue generation for Dr. Sulaiman Al-Habib Medical Services Group is intricately linked to its broad spectrum of services, which includes outpatient care, inpatient treatment, laboratory services, imaging facilities, and pharmaceutical sales. Their diversified service model allows them to serve a wide demographic, catering to the rising demand for specialized medical services in the region. Beyond the conventional healthcare setup, the group also thrives on its foray into digital healthcare solutions, which include telemedicine services and electronic health records, reflecting a keen adaptability to contemporary technological advancements. This adaptive strategy not only enhances operational efficiency but also strengthens patient engagement, thereby ensuring a steady stream of revenue while simultaneously fostering trust and loyalty among its patients. In essence, Dr. Sulaiman Al-Habib Medical Services Group exemplifies a balanced paradigm of healthcare excellence and business acumen, contributing significantly to the elevation of healthcare standards in the Middle East.